Gasy-Go Capsule PR is a combination pharmaceutical product containing Domperidone 30 mg and Pantoprazole 40 mg, formulated for the management of gastrointestinal disorders characterized by symptoms such as acid reflux, heartburn, and delayed gastric emptying. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by increasing the tone of the lower esophageal sphincter and accelerating gastric emptying, thereby alleviating symptoms of nausea, vomiting, and bloating. Pantoprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, leading to reduced gastric acidity and promoting mucosal healing in conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcer disease. The combination of these agents provides a synergistic effect by addressing both motility and acid-related components of upper gastrointestinal disorders. Gasy-Go Capsule PR is indicated for adult patients requiring symptomatic relief from dyspepsia, GERD, and functional dyspepsia with delayed gastric emptying. It should be used under medical supervision, considering contraindications such as hypersensitivity to components, and caution is advised in patients with cardiac arrhythmias or hepatic impairment. Adverse effects may include headache, dry mouth, and gastrointestinal disturbances.